BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 13, 2012
View Archived Issues
Frontier Biotechnologies presents early clinical data for albuvirtide
Read More
Cubist Pharmaceuticals presents novel, broad-spectrum cephalosporin
Read More
New peptidase inhibitors patented by GlaxoSmithKline
Read More
Actelion Pharmaceuticals presents novel orexin receptor antagonists
Read More
New GPR119 receptor agonists patented by LG Life Sciences
Read More
Amgen synthesizes novel BACE inhibitors
Read More
Czech group presents novel NMDA receptor antagonists
Read More
Bristol-Myers Squibb discloses new HCV inhibitors
Read More
Results reported from phase II studies of BI-671800 in adult asthma
Read More
Hybrigenics begins phase II trial of oral inecalcitol in CLL
Read More
Immunetics awarded NIH contract for blood screening test
Read More
Galapagos presents promising in vivo results for GLPG-0492
Read More
Osmotica Pharmaceutical and Panacea Biotec form strategic alliance
Read More
e-Therapeutics begins second phase I trial of ETS-2101 in cancer
Read More
ReNeuron files two U.K. clinical trial applications and updates stem cell therapy pipeline
Read More
Oncolytics modifies phase III study of Reolysin
Read More
Visterra and Pfizer to collaborate on novel antibody discovery
Read More
KaloBios begins phase II study of MAb for asthma
Read More
Topline phase III data reported for rifamycin SV MMX
Read More
Healthpoint Biotherapeutics begins phase III trial for venous leg ulcers
Read More
FDA approves Genzyme's MS therapeutic
Read More
First launch of Eisai's antiepileptic agent announced in Europe
Read More
FDA accepts Otsuka's NDA resubmission
Read More
Sunesis plans to increase sample size in pivotal VALOR trial
Read More
Mitsubishi Tanabe seeks Japanese approval for Maintate
Read More